{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:33:12Z","timestamp":1793298792599,"version":"4.5.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Vaginal estrogen may improve urgency urinary incontinence (UUI) while systemic estrogen may worsen urinary incontinence (UI). Low testosterone is linked to UI. Sex hormone\u2013binding globulin (SHBG) binds circulating estrogen and testosterone, reducing bioavailability and potentially affecting genitourinary function by limiting local hormone availability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The objectives of this study were to investigate the relationship between UI and SHBG levels, bioavailable estrogen, and testosterone in postmenopausal women. We hypothesized that women with higher SHBG levels would be more likely to have urgency and stress urinary incontinence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Design<\/jats:title>\n                    <jats:p>This was a cross-sectional analysis of National Health and Nutrition Examination Survey (NHANES) data from 2013 to 2016, including serum measurements of SHBG, estradiol, and testosterone. Bioavailable hormones were calculated using hormone\/SHBG ratios. The analysis examined hormone levels in women with urgency, stress, and mixed incontinence. Descriptive statistics, weighted analysis of covariance, and weighted logistic regression were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 2,318 postmenopausal women with SHBG measurements, 1,522 (65.7%) reported stress or urgency UI. After adjusting for age, body mass index, race, smoking status, and vaginal deliveries, women with UUI had significantly higher SHBG than those without UUI (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.0214). Women with UUI had significantly lower free estrogen (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.0433) and free testosterone (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.0025). The odds of experiencing UUI increased 1.37-fold when SHBG was \u226565\u00a0nmol\/L (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.0134).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Higher SHBG levels and lower free estrogen and testosterone are associated with UUI in postmenopausal women, suggesting bioavailable hormones play crucial roles in maintaining genitourinary tract function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/spv.0000000000001817","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:00:10Z","timestamp":1773932410000},"page":"305-311","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Sex Hormone\u2013Binding Globulin in Postmenopausal Women With Urinary Incontinence"],"prefix":"10.1097","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2847-5249","authenticated-orcid":false,"given":"Marie E.","family":"Sullivan","sequence":"first","affiliation":[{"name":"Urogynecology and Pelvic Reconstructive Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joni K.","family":"Evans","sequence":"additional","affiliation":[{"name":"Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"El Haraki","sequence":"additional","affiliation":[{"name":"Urogynecology and Pelvic Reconstructive Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4]]},"reference":[{"issue":"8","key":"R1-20260508","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00192-019-04070-0","article-title":"Effectiveness of hormones in postmenopausal pelvic floor dysfunction-International Urogynecological Association research and development-committee opinion","volume":"31","author":"Bodner-Adler","year":"2020","journal-title":"Int Urogynecol J"},{"issue":"2","key":"R2-20260508","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.AOG.0000107290.33034.6f","article-title":"Postmenopausal hormone therapy and risk of developing urinary incontinence","volume":"103","author":"Grodstein","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"8","key":"R3-20260508","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jama.293.8.935","article-title":"Effects of estrogen with and without progestin on urinary incontinence","volume":"293","author":"Hendrix","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"R4-20260508","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.juro.2017.08.093","article-title":"The association of serum testosterone levels and urinary incontinence in women","volume":"199","author":"Kim","year":"2018","journal-title":"J Urol"},{"issue":"8","key":"R5-20260508","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1007\/s11255-024-03996-9","article-title":"Associations between serum testosterone levels and overactive bladder in women: a cross-sectional research of NHANES 2011 to 2016","volume":"56","author":"Li","year":"2024","journal-title":"Int Urol Nephrol"},{"issue":"7","key":"R6-20260508","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00192-022-05221-6","article-title":"Correction to: Stress urinary incontinence and the forgotten female hormones","volume":"33","author":"Siddle","year":"2022","journal-title":"Int Urogynecol J"},{"issue":"11","key":"R7-20260508","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1097\/GME.0000000000001587","article-title":"Expression of androgen receptors in the structures of vulvovaginal tissue","volume":"27","author":"Palacios","year":"2020","journal-title":"Menopause"},{"issue":"8","key":"R8-20260508","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/00016340903117986","article-title":"The relation between urinary incontinence and steroid hormone levels in perimenopausal women. A report from the Women\u2019s Health in the Lund Area (WHILA) study","volume":"88","author":"Teleman","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4 Suppl 1","key":"R10-20260508","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0090-4295(03)00676-9","article-title":"The role of estrogens in female lower urinary tract dysfunction","volume":"62","author":"Robinson","year":"2003","journal-title":"Urology"},{"issue":"4","key":"R11-20260508","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.sxmr.2018.03.005","article-title":"Role of androgens in female genitourinary tissue structure and function: implications in the genitourinary syndrome of menopause","volume":"6","author":"Traish","year":"2018","journal-title":"Sex Med Rev"},{"issue":"7","key":"R12-20260508","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/GME.0000000000001138","article-title":"The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women\u2019s Sexual Health (ISSWSH) expert consensus panel review","volume":"25","author":"Simon","year":"2018","journal-title":"Menopause"},{"issue":"8","key":"R13-20260508","first-page":"2832","article-title":"A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition","volume":"85","author":"Burger","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"R14-20260508","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/frne.2001.0216","article-title":"DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology","volume":"22","author":"Labrie","year":"2001","journal-title":"Front Neuroendocrinol"},{"issue":"3","key":"R15-20260508","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/GME.0000000000002485","article-title":"Prevalence of urinary tract infections in women with vulvovaginal atrophy and the impact of vaginal prasterone on the rate of urinary tract infections","volume":"32","author":"Rubin","year":"2025","journal-title":"Menopause"}],"container-title":["Urogynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SPV.0000000000001817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:00:23Z","timestamp":1778274023000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SPV.0000000000001817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":14,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/spv.0000000000001817","relation":{},"ISSN":["2771-1897"],"issn-type":[{"value":"2771-1897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"2025-08-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}